EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ginsenoside Rg1 Prevents and Treats Acute Pulmonary Injury Induced by High-Altitude Hypoxia

Junru Chen, Zhuo Zhang iD, Mingyue Huang, Jiayi Yan, Rong Gao, Jialu Cui, Yue Gao, Zengchun Ma

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252212051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Junru Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Ginsenosides, Acute Lung Injury. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the protective effects of ginsenoside Rg1 on high-altitude hypoxia-induced acute lung injury (ALI) and elucidated its molecular targets and related pathways, specifically its association with the fluid shear stress pathway. Using a combination of bioinformatics analysis and both in vivo and in vitro experiments, we assessed the role of ginsenoside Rg1 in mitigating physiological and biochemical disturbances induced by hypoxia. In the in vivo experiments, we measured arterial blood gas parameters, levels of inflammatory cells and cytokines, erythrocyte and platelet parameters, and conducted histological analysis in rats. The in vitro experiments utilized human pulmonary microvascular endothelial cells (HPMECs) and A549 cells to examine cell viability, intracellular reactive oxygen species (ROS) and Ca2⁺ levels, and mitochondrial function. The results of the in vivo experiments demonstrate that ginsenoside Rg1 significantly increased arterial blood oxygen partial pressure and saturation, elevated arterial blood glucose levels, and stabilized respiratory and metabolic functions in rats. It also reduced inflammatory cells and cytokines, such as tumor necrosis factor-α and interleukin-6, and improved erythrocyte and platelet abnormalities, supporting its protective role through the regulation of the fluid shear stress pathway. Histological and ultrastructural analyses revealed that Rg1 significantly protected lung tissue structure and organelles. In vitro experiments further confirmed that Rg1 improved cell viability in HPMEC and A549 cells under hypoxic conditions, decreased intracellular ROS and Ca2⁺ levels, and enhanced mitochondrial function. These findings collectively demonstrate that ginsenoside Rg1 exerts significant protective effects against high-altitude hypoxia-induced ALI by enhancing oxygen delivery and utilization, reducing inflammatory responses, and maintaining cellular metabolism and vascular function. Notably, the protective effects of Rg1 are closely associated with the regulation of the fluid shear stress pathway, suggesting its potential for treating high-altitude hypoxia-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesAcute Lung InjuryAnimalsHumansRatsA549 CellsMaleReactive Oxygen SpeciesHypoxiaCytokinesRats, Sprague-DawleyMitochondriaCell SurvivalEndothelial CellsLungAltitudeAltitude Sickness

Stichwörter der Autor:innen

acute lung injuryfluid shear stressginsenoside Rg1high-altitude hypoxiainflammationmitochondrial function

Substanzen

Ginsenosidesginsenoside Rg1Reactive Oxygen SpeciesCytokines

Autor:innen und Institutionen

  • School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China.
  • Department of Pharmaceutical Sciences, Beijing Institute of Radiation Medicine, Beijing 100850, China.
  • Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.

ORCID-Profile: Zhuo Zhang

Förderung

  • National Key Research and Development Program
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • National Natural Science Foundation of China
  • National Key R&D Program of China

Zitieren

APA

Chen, J., Zhang, Z., Huang, M., Yan, J., Gao, R., Cui, J., Gao, Y., & Ma, Z. (2024). Ginsenoside Rg1 Prevents and Treats Acute Pulmonary Injury Induced by High-Altitude Hypoxia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212051

Vancouver

Chen J, Zhang Z, Huang M, Yan J, Gao R, Cui J, et al. Ginsenoside Rg1 Prevents and Treats Acute Pulmonary Injury Induced by High-Altitude Hypoxia. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212051

BibTeX
@article{Chen2024,
  author = {Chen, Junru and Zhang, Zhuo and Huang, Mingyue and Yan, Jiayi and Gao, Rong and Cui, Jialu and Gao, Yue and Ma, Zengchun},
  title = {Ginsenoside Rg1 Prevents and Treats Acute Pulmonary Injury Induced by High-Altitude Hypoxia},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252212051}
}
Kostenlos starten →